Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Telomir Pharmaceuticals, Inc. | CEO & Chairman, Director | Common Stock | 976K | Feb 8, 2024 | Direct | ||
MyMD Pharmaceuticals, Inc. | President, Chief Med. Officer, Director | Employee Stock Option (Right to Buy) | 300K | Jun 7, 2023 | Direct | ||
MIRA PHARMACEUTICALS, INC. | Executive Chairman, Director | Stock Options | 50K | Aug 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TELO | Telomir Pharmaceuticals, Inc. | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | CEO & Chairman, Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Aug 17, 2023 | 1 | $0 | 4 | Aug 21, 2023 | Executive Chairman, Director |
MIRA | MIRA PHARMACEUTICALS, INC. | Aug 2, 2023 | 0 | $0 | 3 | Aug 2, 2023 | Executive Chairman, Director |
MYMD | MyMD Pharmaceuticals, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | President, Chief Med. Officer, Director |
MYMD | MyMD Pharmaceuticals, Inc. | Apr 4, 2023 | 1 | $0 | 4 | Apr 5, 2023 | President, Chief Med. Officer, Director |
MYMD | MyMD Pharmaceuticals, Inc. | Oct 14, 2021 | 1 | $0 | 4 | Oct 15, 2021 | President, Chief Med. Officer, Director |